4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-21-000070
CIK 0001640455other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:15 PM ET
Size
4.7 KB
Accession
0001640455-21-000070
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Sale
Common Stock
2021-03-15$12.80/sh−200$2,560→ 9,913 total
Footnotes (1)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2020. The Reporting Person exercised no discretion with respect to these transactions.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 9:15 PM ET
- Size
- 4.7 KB